Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans

Journal of Clinical Microbiology

Volumn 36, Issue 5, 1998, Pages 1330-1332

  Kirkpatrick, William R ^a   Mcatee, Robert K ^a   Revankar, Sanjay G ^a   Fothergill, Annette W ^a   Mccarthy, Dora I ^a   Rinaldi, Michael G ^a   Patterson, Thomas F ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; FLUCONAZOLE; GLUCOSE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIUM; DILUTION; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STANDARD;

FILOBASIDIELLA NEOFORMANS;

EID: 0031979843     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.5.1330-1332.1998     Document Type: Article

References (22)

1. Barchesi, F., A. L. Colombo, D. A. McGough, and M. G. Rinaldi. 1994. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard. J. Clin. Microbiol. 32:2494-2500.
2. Barchesi, F., R. J. Hollis, S. A. Messer, G. Scalise, M. G. Rinaldi, and M. A. Pfaller. 1995. Electrophoretic karyotype and in vitro susceptibility of Cryptococcus neoformans isolates from AIDS patients. Diagn. Microbiol. Infect. Dis. 23:99-103.
3. Brandt, M. E., M. A. Pfaller, R. A. Hajjeh, E. A. Gravis, J. Rees, E. D. Spitzer, R. W. Pinner, L. W. Mayer, and the Cryptococcal Disease Active Surveillance Group. 1996. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated cryptococcosis. J. Infect. Dis. 174:812-820.
4. Casadevall, A., E. D. Spitzer, D. Webb, and M. G. Rinaldi. 1993. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob. Agents Chemother. 37:1383-1386.
5. Chen, S. C. A., M. L. O'Donnell, S. Gordon, and G. L. Gilbert. 1996. Antifungal susceptibility testing using the E-test: comparison with the broth macrodilution technique. J. Antimicrob. Chemother. 37:265-273.
6. Colombo, A. L., F. Barchiesi, D. A. McGough, and M. G. Rinaldi. 1995. Comparison of E-test and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J. Clin. Microbiol. 33:535-540.
7. Dermoumi, H. 1992. In vitro susceptibility of yeast isolates from the blood to fluconazole and amphotericin B. Chemotherapy 38:112-117.
8. Espinel-Ingroff, A., L. Steele-Moore, and J. N. Galgiani. 1994. Evaluation of 80% inhibition standards for the determination of fluconazole minimum inhibitory concentrations in three laboratories. Diagn. Microbiol. Infect. Dis. 20:81-86.
9. Fromtling, R. A., J. N. Galgiani, M. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartleu, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
10. Ghannoum, M. A., Y. Fu, A. S. Ibrahim, L. A. Mortara, M. C. Shafiq, J. E. Edwards, Jr., and R. S. Criddle. 1995. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans. Antimicron. Agents Chemother. 39:2459-2465.
11. Millon, L., A. Manteaux, G. Reboux, C. Drobacheff, M. Monod, T. Barale, and Y. Michel-Briand. 1994. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J. Clin. Microbiol. 32:1115-1118.
12. National Committee fur Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. Patterson, T. F. 1997. Cryptococcosis in HIV-infected and non-HIV-infected hosts. Int. J. Infect. Dis. 1(Suppl. 1):S64-S69.
14. Patterson, T. F., W. R. Kirkpatrick, S. G. Revankar, R. K. McAtee, A. W. Fothergill, D. I. McCarthy, and M. G. Rinaldi. 1996. Comparative evaluation of macrodilution and chromogenic agar screening for fluconazole susceptibility of Candida albicans. J. Clin. Microbiol. 34:3237-3239.
15. Patterson, T. F., S. G. Revankar, W. R. Kirkpatrick, O. P. Dib, A. W. Fothergill, S. W. Redding, D. A. Sutton, and M. G. Rinaldi. 1996. Simple method for detecting fluconazole-resistant yeasts with chromogenic agar. J. Clin. Microbiol. 34:1794-1797.
16. Pfaller, M. A., and A. L. Berry. 1994. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32:1992-1996.
17. Powderley, W. G. 1996. Editorial response: management of cryptococcal meningitis - have we answered all the questions? Clin. Infect. Dis. 22:329-330.
18. Rex, J. H., M. A. Pfaller, A. L. Barry, P. W. Nelson, and C. W. Webb. 1995. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob. Agents Chemother. 39:40-44.
19. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, and A. L. Berry. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
20. Rex, J. H., M. A. Pfaller, M. G. Rinaldi, A. Polak, and J. N. Galgiani. 1993. Antifungal susceptibility testing. Clin. Microbiol. Rev. 6:367-381.
21. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
22. Witt, M. D., R. J. Lewis, R. A. Larsen, E. N. Milefchik, M. A. E. Leal, R. H. Haubrich, J. A. Richie, J. E. Edwards, Jr., and M. A. Ghannoum. 1996. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin. Infect. Dis. 22:322-328.